NCT06526884Completed
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions \[UVAS\] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 570 (actual)
- First submitted
- 17 Jul 2024
- Start date
- 22 Jul 2024
- Primary completion date
- 20 Jan 2026
- Lead sponsor
- University of California, Los Angeles
- Diseases
- Heart failure
- NCT number
- NCT06526884
What you commit to
- Study type: Interventional
- Participants enrolled: 570
- From 22 Jul 2024 to the primary completion date, 20 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Undergoing workup for solid organ transplant
- Requiring inpatient procedure or surgery defined by the presence of an anesthesia event or operating room encounter.
Other illness
- Heart or lung transplant recipient with concern for graft dysfunction
- Active malignant cancer (per Council of State and Territorial Epidemiologists value set)
- Pulmonary arterial hypertension (per Joint Commission value set)
- Interstitial lung disease (including pulmonary fibrosis) (per Higher Level 7 value set)
Other
- Pregnant
- Enrolled in hospice
- Admitted to a critical care service
- ED deems discharge unsafe due to complex social or medical factors
- The ED deems discharge unsafe due to complex social or medical factors.
- Transferred to an ineligible hospital
- Note:
- The Health System plans to limit the volume of referrals to the NDC by only referring patients who have an even birth date (this is more equitable than first-come-first-serve, because wage workers are more likely to come to the ED later in the day; even/odd birth date theoretically keeps more spots open for patients presenting to the ED later).
Who the study is looking for
- 18 years of age or older
- About to be admitted through the ED for one of the NDC diagnoses or a synonym (per Study Protocol document), defined by the presence of a Plan to Admit order or Bed Request order, OR recently admitted under observation or inpatient status for one of the NDC diagnoses.
- Identified as at-risk for an avoidable hospitalization in the ED based on a pre-determined set of lab and vital parameters.
- Insurance that authorizes the patient to follow-up at UCLA Health, or self-pay
- Admitted or being admitted to an internal medicine service
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ronald Reagan UCLA Medical Center Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.